JP2018500336A5 - - Google Patents

Download PDF

Info

Publication number
JP2018500336A5
JP2018500336A5 JP2017532657A JP2017532657A JP2018500336A5 JP 2018500336 A5 JP2018500336 A5 JP 2018500336A5 JP 2017532657 A JP2017532657 A JP 2017532657A JP 2017532657 A JP2017532657 A JP 2017532657A JP 2018500336 A5 JP2018500336 A5 JP 2018500336A5
Authority
JP
Japan
Prior art keywords
compound
cantharidin
iii
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017532657A
Other languages
English (en)
Japanese (ja)
Other versions
JP6810693B2 (ja
JP2018500336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/066487 external-priority patent/WO2016100732A2/en
Publication of JP2018500336A publication Critical patent/JP2018500336A/ja
Publication of JP2018500336A5 publication Critical patent/JP2018500336A5/ja
Application granted granted Critical
Publication of JP6810693B2 publication Critical patent/JP6810693B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017532657A 2014-12-17 2015-12-17 カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成 Active JP6810693B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462093396P 2014-12-17 2014-12-17
US62/093,396 2014-12-17
PCT/US2015/066487 WO2016100732A2 (en) 2014-12-17 2015-12-17 Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020206344A Division JP2021073173A (ja) 2014-12-17 2020-12-11 カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成

Publications (3)

Publication Number Publication Date
JP2018500336A JP2018500336A (ja) 2018-01-11
JP2018500336A5 true JP2018500336A5 (enExample) 2019-02-07
JP6810693B2 JP6810693B2 (ja) 2021-01-06

Family

ID=56127857

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017532657A Active JP6810693B2 (ja) 2014-12-17 2015-12-17 カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成
JP2020206344A Pending JP2021073173A (ja) 2014-12-17 2020-12-11 カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成
JP2023212697A Active JP7777726B2 (ja) 2014-12-17 2023-12-18 カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020206344A Pending JP2021073173A (ja) 2014-12-17 2020-12-11 カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成
JP2023212697A Active JP7777726B2 (ja) 2014-12-17 2023-12-18 カンタリジンおよび生理活性カンタリジン誘導体の商業的に実現可能な合成

Country Status (12)

Country Link
US (2) US10745413B2 (enExample)
EP (1) EP3233865A4 (enExample)
JP (3) JP6810693B2 (enExample)
KR (1) KR102528106B1 (enExample)
CN (2) CN114106013A (enExample)
AU (2) AU2015364524A1 (enExample)
BR (1) BR112017013029B1 (enExample)
CA (1) CA2971279C (enExample)
HK (1) HK1246276A1 (enExample)
IL (2) IL252907B2 (enExample)
MX (2) MX385473B (enExample)
WO (1) WO2016100732A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL283432B2 (en) 2013-08-21 2025-02-01 Verrica Pharmaceuticals Inc Compositions, methods and systems for treating skin disorders
CN114106013A (zh) 2014-12-17 2022-03-01 维里卡制药有限公司 斑螯素和生物活性斑螯素衍生物的商业上可行的合成
JP6898241B2 (ja) 2015-01-20 2021-07-07 ヴェリカ ファーマシューティカルズ, インコーポレイテッドVerrica Pharmaceuticals, Inc. 医薬品グレードカンタリジンの定量および調製
CN106674248B (zh) * 2016-12-17 2019-02-26 重庆市中药研究院 一种斑蝥素的合成工艺
JP7280870B2 (ja) 2017-06-06 2023-05-24 ヴェリカ ファーマシューティカルズ インコーポレーテッド 皮膚障害の処置
USD900312S1 (en) 2017-06-15 2020-10-27 Verrica Pharmaceuticals, Inc. Applicator
JP7497980B2 (ja) 2017-06-15 2024-06-11 ヴェリカ ファーマシューティカルズ インコーポレーテッド 体表面の障害の処置のためのデバイスおよび方法
EP4339199A3 (en) * 2017-10-04 2024-05-15 Verrica Pharmaceuticals, Inc. Synthesis of cantharidin
US20210393570A1 (en) * 2017-10-31 2021-12-23 Université de Bourgogne Therapeutical compositions for use in the treatment of non-malignant conditions associated with phosphatidylinositol-3-kinase activation: overgrowth spectrum, cutaneous capillary malformations and seborrheic keratoses
CN113455515A (zh) * 2021-06-24 2021-10-01 广东省农业科学院果树研究所 斑蝥素在制备防治柑橘采后绿霉菌的农药杀菌剂的应用
KR20240012182A (ko) 2022-07-20 2024-01-29 고려대학교 산학협력단 칸타리딘을 유효성분으로 포함하는 교모세포종 예방 또는 치료용 조성물

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4739621Y1 (enExample) 1968-04-18 1972-11-30
US4148917A (en) 1977-06-13 1979-04-10 The Procter & Gamble Company Dermatological compositions
US4298752A (en) 1980-09-19 1981-11-03 Regents Of The University Of California Cycloadduct precursors of cantharidin and method
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
JP3117502B2 (ja) 1991-08-27 2000-12-18 株式会社資生堂 皮膚外用剤
JPH05255367A (ja) * 1992-02-28 1993-10-05 Jitsuei O カンタリジン誘導体組成物の製造法及びそれを含む抗ウイルス剤
US5445462A (en) 1993-08-03 1995-08-29 Medi-Flex Hospital Products, Inc. Liquid applicator
AU7629694A (en) 1993-08-17 1995-03-14 Schering-Plough Healthcare Products, Inc. Compositions for treating corns, calluses and warts
US5590780A (en) 1995-06-22 1997-01-07 Wheaton Holding, Inc. Unit dose assembly
FR2754175B1 (fr) 1996-10-07 1999-07-02 Oreal Utilisation d'un organopolysiloxane de nature elastomerique associe a une phase organique dans un produit de demaquillage des ongles
US6030633A (en) 1998-05-18 2000-02-29 West Agro, Inc. Film-forming compositions for protecting animal skin
JPH11335303A (ja) 1998-05-26 1999-12-07 Lion Corp 苦味増強方法及び皮膚外用剤
US6337076B1 (en) 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US20030072814A1 (en) 1999-12-16 2003-04-17 Maibach Howard I. Topical pharmaceutical composition for the treatment of warts
WO2002096413A1 (en) * 2001-05-31 2002-12-05 The Chinese University Of Hong Kong Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof
US6899897B2 (en) 2001-06-18 2005-05-31 Jaleva, Inc. Gum resin as a carrier for topical application of pharmacologically active agents
US6673031B2 (en) 2001-09-25 2004-01-06 Phillip Mark Liquid applicator
SI1436321T1 (sl) * 2001-10-19 2006-12-31 Isotechnika Inc Sinteza analogov ciklosporina
JP2004059446A (ja) * 2002-07-25 2004-02-26 Mitsui Chemicals Inc 脂環式化合物及びその製造方法
RU2326893C2 (ru) 2003-04-16 2008-06-20 Кориум Интернэшнл Ковалентное и нековалентное сшивание гидрофильных полимеров и адгезивные композиции, полученные с ними
US20050019418A1 (en) 2003-07-23 2005-01-27 Crutchfield Charles E. Wart treatment
US20070111954A1 (en) 2003-07-23 2007-05-17 Cuticeuticals, Inc. Apparatus and method of wart treatment
JP2005187330A (ja) 2003-12-24 2005-07-14 Lion Corp 歯牙貼布用製品及びゲル組成物の選定方法
FR2865360B1 (fr) 2004-01-22 2006-05-26 Oreal Applicateur comportant un element d'application solidaire, lors de l'utilisation, d'un recipient contenant un produit a appliquer
FR2872704B1 (fr) * 2004-07-12 2007-11-02 Laurent Schwartz Pluritherapie contre le cancer
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20050111900A1 (en) 2004-11-30 2005-05-26 Francesca Fazzolari Ampoule and method of use
FR2885779B1 (fr) 2005-05-23 2007-08-10 Oreal Dispositif de conditionnement et d'application d'un produit cosmetique ou dermatologique
US20070187437A1 (en) 2006-02-10 2007-08-16 Nordson Corporation Dispensing tip for liquid dispensing systems and method of making the same
JP5132071B2 (ja) 2006-03-31 2013-01-30 小林製薬株式会社 皮膚外用剤
DE102006034272A1 (de) 2006-07-18 2008-01-24 Aesculap Ag & Co. Kg Flüssigkeitsspender in der Medizin in Form einer Handhabe sowie dessen Verwendung
CN100465176C (zh) 2006-08-18 2009-03-04 芜湖天远科技开发有限责任公司 一种提取斑蝥素的方法
US20080146674A1 (en) 2006-12-15 2008-06-19 Rosenberg E William Use of gentian violet in treatment of atopic dermatitis
US8518076B2 (en) 2007-01-08 2013-08-27 Advanced Medical Solutions (Plymouth) Limited Surgical adhesive applicator
JP5230023B2 (ja) 2007-01-25 2013-07-10 ハイパーブランチ メディカル テクノロジー， インコーポレイテッド 複数成分製剤などのための塗布器および使用方法
CN101036774B (zh) 2007-04-17 2010-12-29 贵州益佰制药股份有限公司 一种复方斑蝥口服制剂的检测方法
CN101108853B (zh) 2007-07-27 2010-05-26 贵州大学 斑蝥素分离纯化方法
CN100577665C (zh) * 2007-08-16 2010-01-06 广东药学院 一种抗肿瘤活性斑蛰素衍生物及其制备方法
DE102007046600A1 (de) 2007-09-27 2009-04-02 Linhardt Metallwarenfabrik Gmbh & Co Kg Verfahren zum Applizieren eines flüssigen, medizinischen Behandlungsmediums auf einen zu behandelden Bereich sowie Medizinprodukt
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
JP5396125B2 (ja) 2009-03-30 2014-01-22 有限会社日本健康科学研究センター 被膜形成型製剤
EP2485720B1 (en) 2009-10-08 2018-08-22 Bayer Consumer Care AG Low ether composition and delivery apparatus
US20120016320A1 (en) 2010-07-13 2012-01-19 Lin Michael T Method and Device for Liquid Delivery
US20120148520A1 (en) 2010-12-10 2012-06-14 Michael Strobel Organic Iodine Complex Durable Barrier With Antimicrobial Preparations
FR2972928B1 (fr) 2011-03-25 2013-11-29 Urgo Lab Composition contenant une cellulose, une huile vegetale et un solvant volatil, ses utilisations comme pansement
US20120312709A1 (en) 2011-04-12 2012-12-13 Velcera, Inc. Device for storing and dispensing a medicament, and packaging for containing the same
CN102146086B (zh) 2011-04-12 2012-03-07 贵州金桥药业有限公司 一种斑蝥酸钠的制备方法
US9486829B2 (en) 2011-06-04 2016-11-08 Optmed, Inc. Applicator
CN102268006B (zh) 2011-06-15 2013-08-14 北京联合大学生物化学工程学院 一种复合酶提取斑蝥素的方法
US8871801B2 (en) 2011-08-01 2014-10-28 Jacob LEVITT Method of treating acquired perforating dermatosis with cantharidin
CN202920809U (zh) 2012-09-27 2013-05-08 合肥诚者成医药科技有限公司 一种治疗尖锐湿疣的软膏
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
IL283432B2 (en) 2013-08-21 2025-02-01 Verrica Pharmaceuticals Inc Compositions, methods and systems for treating skin disorders
CN103923095A (zh) * 2014-04-23 2014-07-16 遵义医学院 一种去甲基斑蝥素酸钙
US9994584B2 (en) 2014-10-15 2018-06-12 Lixte Biotechnology, Inc. Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid
CN114106013A (zh) 2014-12-17 2022-03-01 维里卡制药有限公司 斑螯素和生物活性斑螯素衍生物的商业上可行的合成
JP6898241B2 (ja) 2015-01-20 2021-07-07 ヴェリカ ファーマシューティカルズ, インコーポレイテッドVerrica Pharmaceuticals, Inc. 医薬品グレードカンタリジンの定量および調製

Similar Documents

Publication Publication Date Title
JP2018500336A5 (enExample)
JP5857970B2 (ja) （アミドアミノアルカン）金属化合物、及び当該金属化合物を用いた金属含有薄膜の製造方法
RU2018144557A (ru) Способ получения (s)-n-(5-((r)-2-(2,5-дифторфенил)пирролидин-1-ил)-пиразоло[1,5-a]пиримидин-3-ил)-3-гидроксипирролидин-1-карбоксамида и его солей
JP2010500343A5 (enExample)
JP2013501803A5 (enExample)
JP2009536618A5 (enExample)
WO2013051670A1 (ja) コバルト系膜形成方法、コバルト系膜形成材料、及び新規化合物
WO2011072887A1 (de) Verfahren zur herstellung von indiumchlordialkoxiden
EP2555625A1 (en) Process for preparing benzoxaboroles
JP2010536802A5 (enExample)
WO2008135594A1 (de) Verfahren zur herstellung von cylohexyl-substituierten phosphinen
Singh et al. Synthesis of arene ruthenium triazolato complexes by cycloaddition of the corresponding arene ruthenium azido complexes with activated alkynes or with fumaronitrile
JP6143057B2 (ja) １，２−ペンタンジオールの製造方法
Nechayev et al. C–F sp 2 bond functionalization mediated by niobium complexes
JPWO2005094993A1 (ja) 水素化促進剤、水素化触媒及びアルケン化合物の製法
EP1994037A1 (de) Magnesiumorganisches synthesemittel
RU2019138773A (ru) Производство транс-[тетрахлорбис(1h-индазол)рутената(iii)] и его композиций
JP2011219475A (ja) 鉄族金属のビス（ペンタジエニル）錯体の製造方法
CN113563207B (zh) 金属有机配合物的制备方法
JP6184283B2 (ja) オキサミド化合物の製造方法
TW201821431A (zh) 化合物、薄膜形成用原料、原子層堆積法用之薄膜形成用原料及薄膜之製造方法
Fraenkel et al. Efficient one-step synthesis of a cis vicinal tertiary diamine and its complexation to a lithium carbanion salt
Brennessel et al. Crystal structures and spectroscopic characterization of MBr2 (CNXyl) n (M= Fe and Co, n= 4; M= Ni, n= 2; Xyl= 2, 6-dimethylphenyl), and of formally zero-valent iron as a cocrystal of Fe (CNXyl) 5 and Fe2 (CNXyl) 9
CN117088852A (zh) 一种克唑替尼中间体的制备及除钯方法
EP3688000B1 (de) Kohlenwasserstoff-lösliche halogen- und thiolat-/magnesium-austauschreagenzien